Review of radiotherapy and hyperthermia in primary cervical cancer

References

• Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005; 4: CD002225
   Google Scholar
• Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, William CJ. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 2001; 358: 781–786
   PubMed Web of Science ®Google Scholar
• Lukka H, Hirte H, Fyles A, Thomas G, Elit L, Johnston M, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer – a meta-analysis. Clin Oncol (R Coll Radiol) 2002; 14: 203–212
   PubMed Web of Science ®Google Scholar
• Vale C. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26: 5802–5812
   PubMed Web of Science ®Google Scholar
• Perez CA, Gillespie B, Pajak T, Hornback NB, Emami B, Rubin P. Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: A report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1989; 16: 551–558
   PubMed Web of Science ®Google Scholar
• Franckena M, van der Zee J. Use of combined radiation and hyperthermia for gynecological cancer. Curr Opin Obstet Gynecol 2010; 22: 9–14
   PubMed Web of Science ®Google Scholar
• Canters RA, Franckena M, van der Zee J, Van Rhoon GC. Complaint-adaptive power density optimization as a tool for HTP-guided steering in deep hyperthermia treatment of pelvic tumors. Phys Med Biol 2008; 53: 6799–6820
   PubMed Web of Science ®Google Scholar
• Franckena M, Canters R, Termorshuizen F, Van Der Zee J, Van Rhoon G. Clinical implementation of hyperthermia treatment planning guided steering: A cross over trial to assess its current contribution to treatment quality. Int J Hyperthermia 2010; 26: 145–157
   PubMed Web of Science ®Google Scholar
• Franckena M, Fatehi D, de Bruijne M, Canters RA, van Norden Y, Mens JW, et al. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 2009; 45: 1969–1978
   PubMed Web of Science ®Google Scholar
• Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 2011; 187: 605–610
   PubMed Web of Science ®Google Scholar
• Gellermann J, Hildebrandt B, Issels R, Ganter H, Wlodarczyk W, Budach V, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: Correlation with response and direct thermometry. Cancer 2006; 107: 1373–1382
   PubMed Web of Science ®Google Scholar
• Gellermann J, Wlodarczyk W, Ganter H, Nadobny J, Fahling H, Seebass M, et al. A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: Validation in a heterogeneous phantom. Int J Radiat Oncol Biol Phys 2005; 61: 267–277
   PubMed Web of Science ®Google Scholar
• Kampinga HH. Cell biological effects of hyperthermia alone or combined with radiation or drugs: A short introduction to newcomers in the field. Int J Hyperthermia 2006; 22: 191–196
   PubMed Web of Science ®Google Scholar
• Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 1989; 16: 535–549
   PubMed Web of Science ®Google Scholar
• Horsman MR, Overgaard J. Hyperthermia: A potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 2007; 19: 418–426
   PubMed Web of Science ®Google Scholar
• Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, et al. Heat shock protein 70: Role in antigen presentation and immune stimulation. Int J Hyperthermia 2002; 18: 563–575
   PubMed Web of Science ®Google Scholar
• Dayanc BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 2008; 24: 41–56
   PubMed Web of Science ®Google Scholar
• Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci USA 2011; 108: 9851–9856
   PubMed Web of Science ®Google Scholar
• Datta N, Bose A, Kapoor HK. Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): A controlled clinical study. Indian Med Gaz 1987; 121: 68–71
   Google Scholar
• Chen H, Jun-Jie F, Wei L. A randomized trial of hyperthermo-radiochemotherapy for uterine cervix cancer. Chin J Clin Oncol 1997; 24: 249–251
   Google Scholar
• Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2001; 17: 97–105
   PubMed Web of Science ®Google Scholar
• Vasanthan A, Mitsumori M, Park JH, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 2005; 61: 145–153
   PubMed Web of Science ®Google Scholar
• Van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–1125
   PubMed Web of Science ®Google Scholar
• Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, et al. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: An update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 2008; 70: 1176–1182
   PubMed Web of Science ®Google Scholar
• Sharma S, Patel FD, Sandhu AP, Gupta BD, Yadav NS. A prospective randomized study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperthermia Oncol 1989; 5: 151–159
   Google Scholar
• Jones EL, Prosnitz LR, Dewhirst MW, Vujaskovic Z, Samulski TV, Oleson JR, et al. In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145–153). Int J Radiat Oncol Biol Phys 2005;63:644
   Google Scholar
• Van der Zee J, van Rhoon GC, Wust P. In regard to Dr. Vasanthan et al. (Int J Radiat Oncol Biol Phys 2005;61:145–153). Int J Radiat Oncol Biol Phys 2005;62:940–941
   Google Scholar
• Lutgens LCHW, van der Zee J, Pijls-Johannesma M, de Haas-Kock DFM, Buijsen J, Mastrigt GAPGV, et al. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix cancer. Cochrane Database Syst Rev 2010; 3: CD006377
   PubMedGoogle Scholar
• Westermann AM, Jones EL, Schem BC, van der Steen-Banasik EM, Koper P, Mella O, et al. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 2005; 104: 763–770
   PubMed Web of Science ®Google Scholar
• Potter R, Dimopoulos J, Georg P, Lang S, Waldhausl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007; 83: 148–155
   PubMed Web of Science ®Google Scholar
• Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002; 12: 260–271
   PubMed Web of Science ®Google Scholar